A layer of smog lingers above the downtown Los Angeles skyline on December 6, 2024. The National Weather Service on December 4 issued an air quality alert for the greater Los Angeles area until midnight on December 6. (Photo by ETIENNE LAURENT / AFP) (Photo by ETIENNE LAURENT/AFP via Getty Images)

Welcome back to Canada Daily, the newsletter on business, economics and politics from Vancouver to Montreal and beyond. If this was forwarded to you, please sign up here . MDA Space has global ambitions , and it seems investors are on board for the ride. Canada’s largest space technology company debuted on the New York Stock Exchange on Thursday in an initial public offering that was more than seven times oversubscribed, according to people familiar with the matter. The top 25 buyers took about 75% of the shares, they said. The $300 million raised in the IPO will be used to pay down debt and pursue acquisition opportunities , said CEO Mike Greenley. MDA wants to buy companies that would expand its footprint in markets such as the US or Europe, or tech firms that can be folded into its supply chain, he said, reiterating plans shared with Bloomberg News in February. Having a subsidiary outside of Canada would help MDA qualify to become a government contractor in other regions. Thanks to the US listing, Greenley said, “we now have improved tools to be able to seek acquisitions from a stronger position.” The stock fell about 8% in New York, reflecting the dilution from the equity issue. Also in this newsletter: a cybersecurity incident at Telus, Brent crude closes above $100 and a robot who can do your chores . The following was produced with the assistance of Bloomberg Automation. Top stories Sun Life and Allianz are weighing bids for HSBC Life Singapore , and some Japanese insurers are too, according to people familiar with the matter. The sale process began this month after HSBC announced a strategic review of the business in January as part of a global streamlining under new CEO Georges Elhedery. Bloomberg Intelligence analyst Steven Lam estimates the transaction could value the unit at $2 billion or more. Charlesbank Capital Partners has agreed to buy a stake in Overbay Capital Partners, valuing the Canadian secondaries firm at C$200 million ($147 million), accordi...

The dollar index (DXY00) on Thursday rose by +0.51% and posted a 3.5-month high. Thursday’s stock slump boosted liquidity demand for the dollar. Also, higher T-note yields on Thursday have strengthened the dollar’s interest rate differentials. Thursday’s US economic news was mostly supportive for the dollar as weekly jobless claims rose less than expected and the Jan trade deficit narrowed more than expected, while Jan housing starts unexpectedly rose to an 11-month high. US weekly initial unemployment claims fell -1,000 to 213,000, showing a stronger labor market than expectations of an increase to 215,000. Join 200K+ Subscribers: US Jan housing starts unexpectedly rose +7.2% m/m to an 11-month high of 1.487 million, stronger than expectations of a decline to 1.341 million. Jan building permits, a proxy for future construction, fell -5.4% m/m to a 5-month low of 1.376 million, weaker than expectations of 1.410 million. The US Jan trade deficit shrank to -$54.5 billion, narrower than expectations of -$66.0 billion. Swaps markets are discounting the odds at 1% for a -25 bp rate cut at the next FOMC policy meeting on March 17-18. The dollar continues to be undercut by a poor outlook for interest rate differentials, with the FOMC expected to cut interest rates by at least -25 bp in 2026, while the BOJ and ECB are expected to raise rates by at least +25 bp in 2026. EUR/USD (^EURUSD) on Thursday fell by -0.45% due to dollar strength. Also, the euro was undercut by Thursday’s comments from the European Union’s economy chief, Valdis Dombrovskis, who said the inflation rate could surpass 3% this year and GDP in the Eurozone could be as much as -0.4 points lower if the war in the Middle East causes crude oil prices to remain around $100 per barrel and gas prices stay elevated for an extended period. Swaps are discounting a 3% chance of a +25 bp rate hike by the ECB at its next policy meeting on March 19. USD/JPY (^USDJPY) on Thursday rose by +0.30%. The yen tumbled to an 8-w...

svetikd/E+ via Getty Images Medical Properties ( MPT ) engineered a reversal in its net profits in 2025 amid a broad-based portfolio restructuring, and the hospital REIT fully supported its dividend with normalized funds from operations in the fourth quarter. The hospital investor has also made considerable progress resolving its exposure to the Prospect Medical Holdings bankruptcy, which is limiting risks for investors and could potentially set the REIT up for normalized FFO growth in 2026. With more positive news coming from Medical Properties, including a 12.5% dividend increase, I believe Medical Properties could be a promising turnaround investment in 2026. Most importantly, shares are really cheap, based off normalized FFO and book value, which translates to a risk profile that is skewed to the upside. Data by YCharts Previous rating I rated Medical Properties a "S trong (speculative) Buy" last year, mainly because I felt that the REIT was overly punished by investors after it lost its anchor tenant, Steward Health Care, to bankruptcy in 2024 and sold off assets to pay down its considerable debt: 1.75X Coverage, Stabilizing FFO, Re-Pricing Catalyst . Medical Properties made progress in restructuring its portfolio, and the hospital REIT fully earned its dividend payout (which was also raised) in the last quarter. I like that MPT is moving forward with asset sales and debt repayments, and 2026 could be a major transition year for the company. Stable debt situation, stabilizing portfolio The REIT's asset divestment strategy in 2024 and 2025 was driven by a loss of key tenants—such as Steward Health Care and Prospect Medical, previously important tenants—and a desire to refocus on a stabilization of Medical Properties' cash flows. While the company sold more than $3.0 billion in assets in 2024, Medical Properties most recently returned to select portfolio acquisitions. As of the end of the most recent quarter, Medical Properties carried $9.7 billion in long-term d...

Nike (NKE 2.87%) CEO Elliott Hill took the reins of the vaunted sportswear giant a year-and-a-half ago with a tall task ahead of him. Hill was asked to turn around the struggling Swoosh, which was facing the biggest drawdown in its history as a publicly traded company. Revenue growth had fallen as low as negative double digits, as Nike was losing share to upstart challengers like Deckers' Hoka and On Holding. Since taking over Nike, Hill has made a lot of changes. He's refreshed the management team, streamlined the organizational structure, and brought the focus of the company back to sport. He's also stepped up investments in innovation, pulled back on legacy styles, and reestablished relationships with key wholesale partners after the company overinvested in the direct-to-consumer channel. Some of those efforts have paid off. Nike's revenue has stabilized with sales up 1% to $12.4 billion in the fiscal second quarter, its most recent one, and it's returned to growth in running, one of its biggest categories. However, Nike has slumped in recent months and is back to hovering around an 8-year low as margins have continued to compress as the company invests in the turnaround. With the share price now below $55, Wall Street has taken notice. Wall Street smells opportunity Barclays upgraded the stock on Wednesday, lifting its rating from neutral to a buy-equivalent and raising its price target from $64 to $73. Barclays noted Nike's improving inventory levels, which should help lift margins, and that the recovery in running could pave the way for the rest of the business. Wells Fargo also recently reiterated its buy-equivalent rating on the stock, though it removed Nike from its list of top picks. Finally, Jefferies said that commentary from Dick's Sporting Goods in its fourth-quarter report gives it confidence in Nike's wholesale recovery. Expand NYSE : NKE Nike Today's Change ( -2.87 %) $ -1.60 Current Price $ 54.10 Key Data Points Market Cap $82B Day's Range $ 54.03 ...

Key Points CEO Elliott Hill has made some improvements in his year-and-a-half running Nike. However, revenue is still flat, and profits are falling. The stock isn't cheap, but if the company can get back to profit growth, the stock should rebound. 10 stocks we like better than Nike › Nike (NYSE: NKE) CEO Elliott Hill took the reins of the vaunted sportswear giant a year-and-a-half ago with a tall task ahead of him. Hill was asked to turn around the struggling Swoosh, which was facing the biggest drawdown in its history as a publicly traded company. Revenue growth had fallen as low as negative double digits, as Nike was losing share to upstart challengers like Deckers' Hoka and On Holding. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » Since taking over Nike, Hill has made a lot of changes. He's refreshed the management team, streamlined the organizational structure, and brought the focus of the company back to sport. He's also stepped up investments in innovation, pulled back on legacy styles, and reestablished relationships with key wholesale partners after the company overinvested in the direct-to-consumer channel. Some of those efforts have paid off. Nike's revenue has stabilized with sales up 1% to $12.4 billion in the fiscal second quarter, its most recent one, and it's returned to growth in running, one of its biggest categories. However, Nike has slumped in recent months and is back to hovering around an 8-year low as margins have continued to compress as the company invests in the turnaround. With the share price now below $55, Wall Street has taken notice. Wall Street smells opportunity Barclays upgraded the stock on Wednesday, lifting its rating from neutral to a buy-equivalent and raising its price target from $64 to $73. Barclays noted Nike's improving inventory levels, which should h...

【有線新聞】全國人大表決通過的《生態環境法典》，整合了過去30多部有關生態環境領域的法律，範圍從以往的整治污染、擴展到整個社會生產和消費系統，通過法治手段推動綠色變革。 「生態環境法典」將於今年8月15日實施，將碳達峰、碳中和目標、應對氣候變化舉措，從政策層面上升為法律制度，確保產業、能源、消費等重點領域的綠色轉型。 法典的一大亮點是整合了過去30多部、100多件分散的生態環境法律法規，解決了法條重複、空白與矛盾的執法痛點，完善司法體系的同時，亦降低執法成本。生態環境部法規與標準司司長趙柯：「在過去不同的法之間，存在著一些重復的條款，整合以後，執法人員直接就選擇一條去適用，就能夠很好地處理當前的環境問題。」 在民生層面，《生態環境法典》除了加強對違法行為的處罰力度，亦積極回應民眾關切的「家門口」環境問題，包括油煙、噪聲、光污染等，並對野生動物造成損害等情況作出人性化規定，當中有特別針對環評報告造假問題。中國政法大學教授王燦發：「另外對環評、監測機構弄虛作假，也都規定了高額罰款，還有沒收違法所得，禁止從業等措施，目的就是要讓造假者付出慘重代價。」 法典同時亦有回應新型生態環境問題，為動力電池、光伏組件等新興產業的廢棄物循環、利用設立規則，以進一步減緩氣候變化，也為未來進一步立法留足了空間。

格隆汇3月13日｜据埃尔比勒省长声明及安全消息人士消息，伊拉克北部马克穆尔一处“自由斗士”（Peshmerga）武装力量与法国联军基地遭无人机袭击，六名法国士兵受伤。

当地时间3月12日，美国弗吉尼亚州奥尔德多米宁大学发生枪击事件，造成1人死亡、2人受伤，枪手也已死亡。执法部门消息人士称，枪手被确认为穆罕默德.贝勒.贾洛，其曾是弗吉尼亚州国民警卫队成员。贾洛曾于2016年承认试图向极端组织“伊斯兰国”(ISIS)提供物质支持，被判处11年监禁，并于2024年12月提前获释。警方表示，两名伤者被送往医院（884301）就医，目前情况稳定。所有受害者均与该大学有关联。美国陆军部长丹.德里斯科尔表示，其中两名伤者为陆军人员。警方表示，目前校园不存在持续威胁。事件发生后，美国烟酒枪炮及爆裂物管理局和联邦调查局已派员协助调查，校方随后宣布当天课程暂停。另据了解，美国联邦调查局正以“恐怖主义”方向对此次枪击事件展开调查。(央视新闻)

Tesla’s Big China Sales Spike Didn’t Excite Investors—Here’s Why TradingView

Tesla’s Big China Sales Spike Didn’t Excite Investors—Here’s Why The Globe and Mail

Source: Bloomberg, 0:00

Key Points Medicare eligibility generally begins at 65. If you're still working, you may want to hold off on enrolling if you have good health coverage. That's not the only reason to wait on Medicare. The $23,760 Social Security bonus most retirees completely overlook › Age 65 is an important milestone in the context of healthcare. That's when most people become eligible to enroll in Medicare. Your initial Medicare enrollment window actually begins three months before the month of your 65th birthday, allowing you to sign up ahead of time and put that coverage in place right away. But if you're still working at age 65, you may want to hold off on enrolling in Medicare. And the reason may surprise you. Will AI create the world's first trillionaire? Our team just released a report on the one little-known company, called an "Indispensable Monopoly" providing the critical technology Nvidia and Intel both need. Continue » The less obvious reason to wait on Medicare If you're still working when you become eligible for Medicare, it may not make sense to sign up if you have good health coverage through your employer. While Medicare Part A, which covers hospital care, is free for most enrollees, Part B, which covers outpatient care, comes with a monthly premium. And why pay that premium if you have a workplace plan you're happy with? But there's a less obvious reason to hold off on Medicare enrollment. Waiting to sign up could allow you to keep contributing to a health savings account, or HSA. HSAs are available to people enrolled in high-deductible health insurance plans. And what's great about them is that they're triple tax-advantaged. With an HSA: Contributions are made with pre-tax dollars Invested funds get to grow tax-free Withdrawals are tax-free as long as they're used for qualifying healthcare expenses Once you enroll in Medicare, though, HSA contributions are banned. This holds true even if you only sign up for Part A, which some people do in conjunction with havin...

Cryo-Cell International ( CCEL ) on Thursday said it received a notice from NYSE American stating the company is not in compliance with certain continued listing standards. The exchange cited the company’s stockholders’ deficit as of November 30, 2025, and net losses in two of its three most recent fiscal years ended November 30, 2023, 2024 and 2025. Cryo-Cell said the notice has no immediate effect on the listing or trading of its common stock and that it plans to submit a compliance plan to the exchange. If accepted, the company could receive up to 18 months to regain compliance. Source: Press Release More on CRYO-CELL International Seeking Alpha’s Quant Rating on CRYO-CELL International Historical earnings data for CRYO-CELL International Financial information for CRYO-CELL International

以军称打击伊朗巴斯基民兵目标 2026-03-13 05:07:31 来源： 同花顺7x24快讯 分享 总台记者获悉，当地时间12日，以色列国防军宣布以色列空军在过去24小时内对伊朗巴斯基民兵近期在德黑兰市内的多个地点设立的检查站发动了空袭。(央视新闻)

加拿大和墨西哥官员周四重申，在美国释放出可能更倾向于推进双边贸易协议的信号之际，维持三国与美国之间的三边自由贸易协定的重要性。 加拿大驻墨西哥大使卡梅伦·麦凯和墨西哥副贸易部长路易斯·罗森多·古铁雷斯在墨西哥城的一场会议上表示，维持美国—墨西哥—加拿大协定（USMCA）这一三边贸易框架是两国的优先事项。 不过，墨西哥经济部长马塞洛·埃布拉德淡化了可能产生的影响，称墨西哥的大部分贸易都在《美墨加协定》（USMCA）框架下进行，因此不受301条款的约束。 责任编辑：陈钰嘉

Strategic initiatives and new customers are delivering improved underlying performance, masked by ongoing sector and macroeconomic environment business pressures Launched significant share of wallet expansions with two major customers and onboarded a new full-service restaurant customer Reduced debt by $2.0 million in the quarter, bringing full year debt reduction to $13.2 million, or 16.4% IRVING, Texas, March 12, 2026 (GLOBE NEWSWIRE) -- Quest Resource Holding Corporation (Nasdaq: QRHC) (“Quest” or the “Company”), a national leader in environmental waste and recycling services, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Highlights Revenue was $58.9 million, a 15.8% decrease compared with the fourth quarter of 2024, and a 7.0% decrease from the third quarter of 2025. Gross profit was $9.1 million, a 15.1% decrease compared with the fourth quarter of 2024, and a 20.6% decrease from the third quarter of 2025. Gross margin was 15.5% of revenue, compared with 15.3% for the fourth quarter of 2024. GAAP net loss was $1.7 million, compared with a net loss of $9.5 million for the fourth quarter of 2024. GAAP net loss per basic and diluted share attributable to common stockholders was $(0.08), compared with $(0.46) for the fourth quarter of 2024. Adjusted EBITDA was $2.1 million, compared with $1.7 million for the fourth quarter of 2024. Fiscal Year 2025 Highlights Revenue was $250.2 million, a 13.3% decrease compared with the same period of 2024. Gross profit was $42.5 million, a 14.9% decrease compared with the same period of 2024. Gross margin was 17.0% of revenue, compared with 17.3% for the same period of 2024. GAAP net loss was $15.4 million, compared with a net loss of $15.1 million for the same period of 2024. GAAP net loss per basic and diluted share attributable to common stockholders was $(0.73), which is consistent with the same period of 2024. Adjusted EBITDA was $9.3 million compared to...

伊朗伊斯兰革命卫队司令顾问贾巴里当地时间12日表示，伊朗拥有开展长期战争的能力和持久作战的实力，并称在之前几天里“已摧毁美国在地区70％的军事基地和指挥部”。贾巴里还表示，伊朗掌握新一代先进导弹系统，目前还未被使用。（央视新闻）

The Global X NASDAQ 100 Covered Call ETF ( QYLD ) boasts an almost 12% yield. But does this make it a good income-generating investment long-term? In this analysis, I want to explain why QYLD’s distributions and total returns behaved a certain way. This ETF's portfolio construction is transparent. But it does not mean that it works on the Nasdaq-100. Historically, QYLD has not produced a favorable result for income-seeking investors. Other similar covered call ETFs do a better job by mitigating QYLD’s structural issues. QYLD Portfolio Construction in a Nutshell QYLD has been around since 2013. It is one of the oldest covered call ETFs that is appealing to income investors. The concept behind it is relatively simple to understand. The fund buys the Nasdaq-100 and then sells at-the-money call options on it on a monthly basis. At-the-money options generate income that QYLD distributes to investors on a monthly basis. The fund has a rule that it does not distribute all of the premium income received. Instead, QYLD distributes 50% of the premiums received or 1% of the fund’s net asset value, whichever is lower. The remaining balance gets reinvested back into the fund. Why QYLD’s Covered Call Strategy Does Not Work on Nasdaq-100 Here is why QYLD’s investment process does not work on the Nasdaq-100, in my opinion. The Nasdaq-100 is very volatile and growth-oriented. It can make strong moves to both the upside and the downside. The most important job of a covered call ETF is to capture as much of that upside while keeping its downside low. To capture this upside, covered call funds have two main levers to pull. First is portfolio coverage by sold call options. If a fund sells call options on, say, 50% of its stock portfolio, it can capture future upside on the remaining 50%. Many covered call ETFs like QQQI, JEPQ, and GPIQ do not sell call options on their entire portfolios. Conversely, QYLD writes call options on 100% of its portfolio. The upshot is that it captures a lot ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Astera Labs is expanding into European markets through targeted acquisitions. The company is using these deals to build a broader footprint beyond its existing regions. This move marks a shift in its global growth approach that had not been highlighted in earlier updates. For investors tracking NasdaqGS:ALAB, this acquisition-led expansion adds a new piece to the story beyond prior discussion of partnerships, margins, and product mix. The shares trade at $124.71, with a 7 day return of 9.6% and a 1 year return of 81.2%, while the year to date return sits at a 30.5% decline and the 30 day return at a 33.5% decline. Europe-focused acquisitions could change how you think about where future revenue might come from and how the business is positioned globally. As the company integrates these deals, the key questions will be execution, the quality of acquired assets, and how well they align with Astera Labs’ existing product and customer base. Stay updated on the most important news stories for Astera Labs by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Astera Labs. NasdaqGS:ALAB 1-Year Stock Price Chart See which insiders are buying and buying and selling Astera Labs following this latest news. Quick Assessment ✅ Price vs Analyst Target : At $124.71, the share price sits about 40% below the consensus analyst target of $206.75. ❌ Simply Wall St Valuation : Shares are trading around 37% above Simply Wall St's estimated fair value, which flags a rich valuation. ❌ Recent Momentum: The 30 day return of about 33.5% decline shows weak recent momentum despite the acquisition news. There is only one way to know the right time to buy, sell or hold Astera Labs. Head to Simply Wall St's company report for the latest analysis of Astera Labs's Fair Value. Key Considerations 📊 Europe ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Astera Labs is expanding into European markets through targeted acquisitions. The company is using these deals to build a broader footprint beyond its existing regions. This move marks a shift in its global growth approach that had not been highlighted in earlier updates. For investors tracking NasdaqGS:ALAB, this acquisition-led expansion adds a new piece to the story beyond prior discussion of partnerships, margins, and product mix. The shares trade at $124.71, with a 7 day return of 9.6% and a 1 year return of 81.2%, while the year to date return sits at a 30.5% decline and the 30 day return at a 33.5% decline. Europe-focused acquisitions could change how you think about where future revenue might come from and how the business is positioned globally. As the company integrates these deals, the key questions will be execution, the quality of acquired assets, and how well they align with Astera Labs’ existing product and customer base. Stay updated on the most important news stories for Astera Labs by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new perspectives on Astera Labs. NasdaqGS:ALAB 1-Year Stock Price Chart See which insiders are buying and buying and selling Astera Labs following this latest news. Quick Assessment ✅ Price vs Analyst Target : At $124.71, the share price sits about 40% below the consensus analyst target of $206.75. ❌ Simply Wall St Valuation : Shares are trading around 37% above Simply Wall St's estimated fair value, which flags a rich valuation. ❌ Recent Momentum: The 30 day return of about 33.5% decline shows weak recent momentum despite the acquisition news. There is only one way to know the right time to buy, sell or hold Astera Labs. Head to Simply Wall St's company report for the latest analysis of Astera Labs's Fair Value. Key Considerations 📊 Europe ...

Astera Labs Europe Acquisitions Reshape Growth Story And Rich Valuation finance.yahoo.com

April Nymex natural gas (NGJ26) on Thursday closed up +0.024 (+0.75%). Nat-gas prices on Thursday rallied in sympathy with crude oil and European gas prices amid the Iran war, which is dragging on. Iran's Supreme Leader Ayatollah Mojtaba Khamenei said on Thursday that Iran's leverage of closing the Strait of Hormuz should be used, and attacks on Gulf Arab neighbors will continue. Also, UK Defense Secretary Healey said it is increasingly evident that Iran is laying mines in the Strait of Hormuz, which would keep the waterway closed for the foreseeable future. Don’t Miss a Day: Nat-gas prices fell back from their best level after EIA nat-gas inventories fell -38 bcf for the week ended March 6, a smaller draw than expectations of -41 bcf. Mixed weather forecasts also weighed on nat-gas prices, as the Commodity Weather Group forecast well-above-average temperatures across the western half of the US from March 17-21, and cooler readings in the East. Nat-gas prices surged last week, with European nat-gas prices climbing to a 3-year high last Tuesday due to the war in Iran. Last Monday, Qatar shut its Ras Laffan plant, the world's largest natural gas export facility, after it was targeted by an Iranian drone attack. The Ras Laffan plant accounts for about 20% of global liquefied natural gas supply, and its closure could boost US nat-gas exports. US (lower-48) dry gas production on Thursday was 112.3 bcf/day (+5.3% y/y), according to BNEF. Lower-48 state gas demand on Thursday was 84.7 bcf/day (+7.8% y/y), according to BNEF. Estimated LNG net flows to US LNG export terminals on Thursday were 20.2 bcf/day (+5.4% w/w), according to BNEF. Projections for higher US nat-gas production are bearish for prices. On February 17, the EIA raised its forecast for 2026 US dry nat-gas production to 109.97 bcf/day from last month's estimate of 108.82 bcf/day. US nat-gas production is currently near a record high, with active US nat-gas rigs posting a 2.5-year high last Friday. As a positiv...